Insider Transactions in Q2 2025 at Acelyrin, Inc. (SLRN)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2025
|
Ayur Maya Capital Management Company, LP Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
9,334,735
-100.0%
|
-
|
|
May 21
2025
|
Amar Murugan Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
121,587
-100.0%
|
-
|
|
May 21
2025
|
Mina Kim Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
770,833
-100.0%
|
-
|
|
May 21
2025
|
Mina Kim Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
89,526
+10.41%
|
-
|
|
May 21
2025
|
Daniel J. Becker Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,999
-100.0%
|
-
|
|
May 21
2025
|
Dawn Svoronos Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,000
-100.0%
|
-
|
|
May 21
2025
|
Patrick Machado Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
14,675
-100.0%
|
-
|
|
May 21
2025
|
Henry O Gosebruch Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,000
-100.0%
|
-
|
|
May 21
2025
|
Shephard Mpofu Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
121,789
-100.0%
|
-
|
|
May 21
2025
|
Beth C Seidenberg Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
9,790,729
-100.0%
|
-
|
|
May 21
2025
|
Beth C Seidenberg Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
60,000
-100.0%
|
-
|
|
May 15
2025
|
Mina Kim Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,297
-1.53%
|
$42,594
$2.17 P/Share
|
|
May 15
2025
|
Mina Kim Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,851
+4.21%
|
-
|